Enabling allogeneic therapies: CIRM‐funded strategies for immune tolerance and immune evasion
Enabling allogeneic therapies: CIRM‐funded strategies for immune tolerance and immune evasion
About this item
Full title
Author / Creator
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
A major goal for the field of regenerative medicine is to enable the safe and durable engraftment of allogeneic tissues and organs. In contrast to autologous therapies, allogeneic therapies can be produced for many patients, thus reducing costs and increasing availability. However, the need to overcome strong immune system barriers to engraftment p...
Alternative Titles
Full title
Enabling allogeneic therapies: CIRM‐funded strategies for immune tolerance and immune evasion
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_18bf7912416740d5913d52eed3ea233d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_18bf7912416740d5913d52eed3ea233d
Other Identifiers
ISSN
2157-6564
E-ISSN
2157-6580
DOI
10.1002/sctm.20-0079
